You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Sale Disclosure
Mainolfi Nello · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$388.84K
Mainolfi Nello Chief Executive Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
KYMR daily price context
Close on/before transaction
$114.2
Jul 1, 2026
First close after public filing
$114.76
Jul 6, 2026
30-day return after filing
-12.59%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,336 shares @ $116.56
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-295088
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$9.39M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Exercise | Jul 1, 2026 | $166.4K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jul 1, 2026 | $212.41K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jul 1, 2026 | $755.2K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jul 1, 2026 | $2.77M |
| Kymera Therapeutics, Inc. KYMR | Sale | Jul 1, 2026 | $5.1M |
| Kymera Therapeutics, Inc. KYMR Current | Sale | Jul 1, 2026 | $388.84K |
| Kymera Therapeutics, Inc. KYMR | Exercise | Jul 1, 2026 | $0 |